MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$46,685K
Short-term investments
$35,900K
Prepaid expenses
$2,577K
Research and development
tax credits...
$808K
Other receivables
$700K
Total current assets
$86,670K
Operating lease
right-of-use assets
$944K
Property and equipment
$136K
Total assets
$87,750K
Total liabilities and
shareholders' equity
$87,750K
Total liabilities
$67,249K
Total shareholders'
(deficit) equity
$20,501K
Accumulated deficit
-$413,194K
Senior secured
convertible notes
$56,206K
Total current
liabilities
$10,524K
Operating lease
liabilities, net of current...
$519K
Common shares, no par
value, unlimited...
$311,776K
Additional paid-in capital
$66,270K
Pre-funded warrants -
16,412,925 issued and...
$55,649K
Accounts payable and
accrued liabilities
$10,041K
Operating lease
liabilities
$483K
Back
Back
Balance Sheet
source: myfinsight.com
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)